192 related articles for article (PubMed ID: 38228604)
21. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder.
Dvorkin A; Culver KE; Waxman D; Szechtman H; Kolb B
Behav Pharmacol; 2008 Jul; 19(4):271-83. PubMed ID: 18622174
[TBL] [Abstract][Full Text] [Related]
22. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit.
Alkhatib AH; Dvorkin-Gheva A; Szechtman H
Behav Pharmacol; 2013 Feb; 24(1):65-73. PubMed ID: 23249525
[TBL] [Abstract][Full Text] [Related]
23. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Tucci MC; Dvorkin-Gheva A; Graham D; Amodeo S; Cheon P; Kirk A; Peel J; Taji L; Szechtman H
Psychopharmacology (Berl); 2013 May; 227(2):277-85. PubMed ID: 23354534
[TBL] [Abstract][Full Text] [Related]
24. Targeting presynaptic H3 heteroreceptor in nucleus accumbens to improve anxiety and obsessive-compulsive-like behaviors.
Zhang XY; Peng SY; Shen LP; Zhuang QX; Li B; Xie ST; Li QX; Shi MR; Ma TY; Zhang Q; Wang JJ; Zhu JN
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32155-32164. PubMed ID: 33257584
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.
Escobar AP; González MP; Meza RC; Noches V; Henny P; Gysling K; España RA; Fuentealba JA; Andrés ME
Int J Neuropsychopharmacol; 2017 Aug; 20(8):660-669. PubMed ID: 28531297
[TBL] [Abstract][Full Text] [Related]
26. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
Nordstrom EJ; Burton FH
Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
[TBL] [Abstract][Full Text] [Related]
27. Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour.
Wood J; LaPalombara Z; Ahmari SE
Philos Trans R Soc Lond B Biol Sci; 2018 Mar; 373(1742):. PubMed ID: 29352023
[TBL] [Abstract][Full Text] [Related]
28. Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole model of obsessive-compulsive disorder.
Schmidt TT; Rea E; Shababi-Klein J; Panagis G; Winter C
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1083-91. PubMed ID: 23043789
[TBL] [Abstract][Full Text] [Related]
29. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
30. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.
Stein DJ; Van Heerden B; Wessels CJ; Van Kradenburg J; Warwick J; Wasserman HJ
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1079-99. PubMed ID: 10621951
[TBL] [Abstract][Full Text] [Related]
31. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
Wolmarans de W; Brand L; Stein DJ; Harvey BH
Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
[TBL] [Abstract][Full Text] [Related]
32. No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder.
Janikova M; Brozka H; Radostova D; Svoboda J; Stuchlik A
Physiol Behav; 2019 May; 204():241-247. PubMed ID: 30826389
[TBL] [Abstract][Full Text] [Related]
33. Role of the dorsal anterior cingulate cortex in obsessive-compulsive disorder: converging evidence from cognitive neuroscience and psychiatric neurosurgery.
McGovern RA; Sheth SA
J Neurosurg; 2017 Jan; 126(1):132-147. PubMed ID: 27035167
[TBL] [Abstract][Full Text] [Related]
34. Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents.
Kanen JW; Ersche KD; Fineberg NA; Robbins TW; Cardinal RN
Psychopharmacology (Berl); 2019 Aug; 236(8):2337-2358. PubMed ID: 31324936
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of lysosomal enzyme activities by proton pump inhibitors.
Liu W; Baker SS; Trinidad J; Burlingame AL; Baker RD; Forte JG; Virtuoso LP; Egilmez NK; Zhu L
J Gastroenterol; 2013 Dec; 48(12):1343-52. PubMed ID: 23478938
[TBL] [Abstract][Full Text] [Related]
37. Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.
Szechtman H; Eckert MJ; Tse WS; Boersma JT; Bonura CA; McClelland JZ; Culver KE; Eilam D
BMC Neurosci; 2001; 2():4. PubMed ID: 11316464
[TBL] [Abstract][Full Text] [Related]
38. Postpartum Lactation-Mediated Behavioral Outcomes and Drug Responses in a Spontaneous Mouse Model of Obsessive-Compulsive Disorder.
Mitra S; Mucha M; Owen S; Bult-Ito A
ACS Chem Neurosci; 2017 Dec; 8(12):2683-2697. PubMed ID: 28945961
[TBL] [Abstract][Full Text] [Related]
39. Midbrain dopamine neurons arbiter OCD-like behavior.
Xue J; Qian D; Zhang B; Yang J; Li W; Bao Y; Qiu S; Fu Y; Wang S; Yuan TF; Lu W
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2207545119. PubMed ID: 36343236
[TBL] [Abstract][Full Text] [Related]
40. Obsessive-compulsive disorder: Insights from animal models.
Szechtman H; Ahmari SE; Beninger RJ; Eilam D; Harvey BH; Edemann-Callesen H; Winter C
Neurosci Biobehav Rev; 2017 May; 76(Pt B):254-279. PubMed ID: 27168347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
